Geoffrey Ginsburg, MD, PhD, a professor of Medicine (Cardiology), Pathology, Biostatistics and Bioinformatics, and Biomedical Engineering, and a professor in School of Nursing, will leave Duke to assume the role of Chief Medical and Scientific Officer for the National Institutes of Health (NIH) All of Us Research Program, effective January 2022. In this role, Dr. Ginsburg will help direct the national scientific research agenda to improve health and accelerate research using precision medicine.
Dr. Ginsburg has been a visionary leader for Duke University and the School of Medicine for 17 years. He is the founding director of the Center for Applied Genomics & Precision Medicine (CAGPM) and also founding director of MEDx, a partnership between Duke’s Schools of Medicine and Engineering, which is designed to stimulate collaboration and innovation. During his tenure at Duke, Dr. Ginsburg has pioneered translational genomics, the development of novel diagnostics, and precision medicine. With a strong commitment to interdisciplinary science and innovation, he has led projects to develop predictive models for common complex diseases using high dimensional genomic data and developed partnerships with engineering colleagues to develop novel point of care sensors.
Dr. Ginsburg will step down from both directorship roles as he leaves Duke. He will remain on faculty at Duke University as an adjunct professor in the School of Medicine. Dr. Cooney will serve as interim director of CAGPM. Dean Klotman, Provost Sally Kornbluth, and Jerome Lynch, who was recently named dean of Duke’s Pratt School of Engineering, will work together to plan the future direction of MEDx.
We want to thank Dr. Ginsburg for his outstanding service and commitment to Duke and to the School of Medicine. Please join us in congratulating him on this exciting next step in his accomplished career.
Mary E. Klotman, MD, Dean, Duke University School of Medicine
Kathleen Cooney, MD, Chair, Department of Medicine